Ledger.Open graph →
SEC Form D · filed June 11, 2020

AsclepiX Therapeutics, Inc

Offering
$35.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Art Brown · Vancouver, British Columbia, CanadaDirectorPatrick J. Heron · Dublin, IrelandExec · DirectorAnkur L. Jain · New York, NYDirectorMark K. Chin · Dublin, IrelandDirectorHironobu C. Tamba · Walnut Creek, CAExec · DirectorAleksander S. Popel, Phd · Baltimore, MDDirectorBrenton K. Ahrens · Dublin, IrelandDirectorSapna S. Srivastava · Baltimore, MDDirectorWilliam M. Daniher · Walnut Creek, CADirectorRichard C. Jelinek · Walnut Creek, CADirectorAnthony Howcroft · Irvine, CADirectorChris Kneeland · Calgary, Alberta, CanadaDirectorJordan J. Green · Baltimore, MDDirectorStuart Frost · Irvine, CADirectorKevin Thieneman · Hilton Head Island, SCDirectorKevin S. Slawin, Md · Baltimore, MDExec · DirectorSteven S. Altschuler, Md · Baltimore, MDDirectorJoshua S. Barer · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗